We all hope that the predictions about the spread and seriousness of COVID-19 (coronavirus) prove to be unfounded. Whatever course the development of the virus takes, many of the measures that have been taken or are under consideration by governments, businesses and other organisations are already having or will have a significant effect on commercial relationships and commercial life generally.
Due to some unique aspects of the EU Cosmetics Regulation compared to other EU product safety regulations, the cosmetics industry has been particularly impacted by Brexit. Given that Brexit has now taken place, it is timely to reconsider this ongoing impact on industry and provide some guidance on forward-looking planning.
Jamie Humphreys and Tracey Bischofberger
The European Commission released its proposals on a future regulatory framework for AI, favouring mandatory risk-based requirements for high-risk applications, along with targeted amendments to existing EU safety and liability legislation.
On 18 February 2020, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), updated its guidance on medicine licensing post-Brexit “Apply for a licence to market a medicine in the UK”. The update provides further clarity on the UK’s status in the licensing process now that Brexit has taken place.
A New Deal for Consumers: a lot to think about for businesses – changes to EU consumer protection rules will come into force in 2022
Edward Turtle and Tracey Bischofberger
New laws to strengthen consumer protection have come into force and will apply across the EU from 28 May 2022. There is a focus on more transparency online, extending rights to “free” digital services and strong sanctions linked to annual turnover.